Sangamo BioSciences Restructuring Creates A Pipeline Gap, Merits 87% PT Decrease

By: via Benzinga
Wedbush believes Sangamo BioSciences, Inc. (NASDAQ: SGMO) lacks any upside potential until the year 2018, citing the pipeline gap in the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.